Jump Financial »

Brainstorm Cell Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.5k 11k 0.23
2020-09-30 $186k 11k 16.91

More positions owned by Jump Financial

SPDR Dow Jones Industrial Average ETF Trust Etf (DIA)
Invesco QQQ Trust Series 1 Etf (QQQ)
POSCO Holdings Depositary Receipt (PKX)
Vanguard S&P 500 ETF Etf (VOO)
VanEck Semiconductor ETF Etf (SMH)
CME Group Common Stock (CME)
iShares 20 Year Treasury Bond ETF Etf (TLT)
Tesla Common Stock (TSLA)
Intercontinental Exchange Common Stock (ICE)
Technology Select Sector SPDR Fund Etf (XLK)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOGL)
Netflix Common Stock (NFLX)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
Eli Lilly & Co Common Stock (LLY)

View all positions for Jump Financial

Top funds holding Brainstorm Cell Therapeutics

Geode Capital Management
BlackRock
Liberty Wealth Management
Weaver Consulting Group
Susquehanna International
Northern Trust
Raymond James & Associates
Jmac Enterprises
Wells Fargo & Company
Group One Trading
Tru Independence Asset Management 2
Citadel Advisors
Janney Montgomery Scott
Creative Planning
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics